TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia: Dose-response relationship and potential neuroprotective mechanisms

Stroke

Volumn 27, Issue 9, 1996, Pages 1609-1615

  Henrich Noack, P ^a   Prehn, J H M ^a   Krieglstein, J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

apoptosis; cytokines; neuroprotection; nitric oxide; rats

Indexed keywords

NITRIC OXIDE; S NITROSOCYSTEINE; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

EID: 0029819763     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.9.1609     Document Type: Article

References (37)

1. Roberts AB, Sporn MB. The transforming growth factor-β. In: Sporn MB, Roberts AB. Handbook of Experimental Pharmacology, Peptide Growth Factors and Their Receptors I. Heidelberg, Germany: Springer; 1990;95:419-472.
2. Suzumura A, Sawada M, Yamamoto H, Maronouchi T. Transforming growth factor-β suppresses activation and proliferation of microglia in vitro. J Immunol. 1993;151:2150-2158.
3. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H. Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol. 1992;117:395-400.
4. Martinou J-C, Le Van Thai A, Valette A, Weber MJ. Transforming growth factor β1 is a potent survival factor for rat embryo motoneurons. Dev Brain Res. 1990;52:175-181.
5. Toru-Delbauffe D, Baghdassarian-Chalaye D, Gavaret JM, Courtin F, Pomerance M, Pierre M. Effects of transforming growth factor β1 on astroglial cells in culture. J Neurochem. 1990;54:1056-1061.
6. Unsicker K, Flanders KC, Cissel DS, Lafyatis R, Sporn MB. Transforming growth factor-β isoforms in the adult rat central and peripheral nervous system. Neuroscience. 1991;44:613-625.
7. Nichols NR, Laping NJ, Day JR, Finch CE. Increase in transforming growth factor-β1 mRNA in hippocampus during response to entorhinal cortex lesions in intact and adrenalectomized rats. J Neurosci Res. 1991;28:134-139.
8. Morgan TE, Nichols NR, Pasinetti GM, Finch CE. TGF-β1 mRNA increases in macrophage/microglia cells of the hippocampus in response to deafferentiation and kainic acid-induced neurodegeneration. Exp Neural. 1993;120:291-301.
9. 1, mRNA in the infant rat brain. Mol Brain Res. 1992;13: 93-101.
10. Wießner C, Gehrmann J, Lindholm D, Topper R, Kreutzberg GW, Hossmann KA. Expression of transforming growth factor-β1 and interleukin-1β mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol (Berl). 1993;86:439-446.
11. Van der Wal EA, Gomez-Pinllla F, Cotman CW. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. Neurorepon. 1993;4:69-72.
12. Wahl SM, Allen JB, McCartney-Francis N, Morganti-Kossmann MC, Kossmann T, Ellingworth L, Mai UEH, Mergenhagen SE, Orenstein JM. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med. 1991; 173:981-991.
13. Prehn JHM, Peruche B, Unsicker K, Krieglstein J. Isofonn-specific effects of transforming growth factor-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J Neurochem. 1993;60:1665-1672.
14. 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cereb Blood Flow Metah. 1993;13:521-525.
15. Gross CE, Bednar MM, Howard DB, Sporn MB. Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke. 1993;24:558-562.
16. 1 after hypoxic-ischaemic brain injury. Neuroreport. 1994;5:901-904.
17. Rothman SM. Synaptic release of excitatory amino acid neuroiransmitter mediates anoxic neuronal death. J Neurosci. 1984;4:1884-1891.
18. Simon RP, Swan JH, Griffith T, Meldrum BS. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 1984;226:850-852,
19. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. Free radicals in cerebral ischemia. Stroke. 1978;9:445-447.
20. Oliver CN, Starke-Reed PE. Stadtman ER, Liu GJ, Carney JM, Floyd RA. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free oxygen radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci U S A. 1990;87:5144-5147.
21. Nitatori T, Sato N, Wagwi S, Karasawa Y, Araki H, Shibami K, Kaminami E, Uchiyama Y. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci. 1995;15:1001-1011.
22. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjö BK. Models for studying long-term recovery following forebrain ischemia in the rat, II: a 2-vessel occlusion model. Acta Neural Scand. 1984;69:385-401.
23. Seif el Nasr M, Nuglisch J, Krieglstein J. Prevention of ischemia-induced hypothermia by controlling the environmental temperature. J Pharmacol Toxicot Methods. 1992;27:23-26.
24. Prehn JHM, Bindokas VP, Marcuccilli CJ, Krajewski D, Reed JC, Miller RJ. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci U S A. 1994;91:12599-12603.
25. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HSV, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS. A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632.
26. Jacobson MD, Burne JF, Raff MC. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 1994; 13: 1899-1910.
27. Koh J-Y. Wie MB, Gwag BJ, Sensi SL, Canzoniero LMT, Demaro J, Csernansky C, Choi DW. Staurosporine-induced neuronal apoptosis. Exp Neural. 1995;135:153-159.
28. Peruche B, Krieglstein J. Mechanisms of drug actions against neuronal damage caused by ischemia: an overview. Prog Neuro-psychopharmacol Biol Psychiatry. 1993;17:21-70.
29. Nakata N, Kato H, Kogure K. Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res. 1993;605:353-356.
30. Shigeno T, Mima T, Takakura K, Graham DI, Kalo G, Hashimoto Y, Furukawa S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J Neurosci. 1991;11:2914-2919.
31. Nozaki K, Finklestein SP, Beal MF. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J Cereb Blood Flow Metab. 1993;13:221-228.
32. Prehn JHM, Miller RJ. Opposite effects of transforming growth factor-β1 on rapidly- and slowly-triggered excitotoxic neuronal injury. Neuropharmacology. 1996;35:249-256.
33. Lafon-Cazal M, Pietri S. Culcasi M, Bockaert J. NMDA-dependent Superoxide produclion and neurotoxicity. Nature. 1993; 364:535-537.
34. Stamler JS, Single DV, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898-1902.
35. Yoshida Y, Dalkara T. lrikura K, Moskowitz MA. Inhibition of neuronal nitric oxide production by 7-nitro-indazole decreases increases infarct size in focal cerebral ischemia. In: Krieglstein J, Oberpichler-Schwenk H, eds. Pharmacology of Cerebral Ischemia. Stuttgart, Germany: Medpharm Scientific Publishers; 1994:329-334.
36. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effect of cerebral ischemia in mice deficient in neuronal NOS. Science. 1994;265:1883-1885.
37. Goto K, Ishige A, Sakiguchi K, Kzuka S, Sugimoto A, Yuzurihara M, Aburada M, Hosoya E, Kogure K. Effect of cycloheximide on delayed neuronal death in rat hippocampus. Brain Res. 1990; 534:299-302.